484 related articles for article (PubMed ID: 27733554)
41. SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses.
Lai L; Kwa SF; Kozlowski PA; Montefiori DC; Nolen TL; Hudgens MG; Johnson WE; Ferrari G; Hirsch VM; Felber BK; Pavlakis GN; Earl PL; Moss B; Amara RR; Robinson HL
Vaccine; 2012 Feb; 30(9):1737-45. PubMed ID: 22178526
[TBL] [Abstract][Full Text] [Related]
42. HIV-1 conserved elements p24CE DNA vaccine induces humoral immune responses with broad epitope recognition in macaques.
Kulkarni V; Valentin A; Rosati M; Rolland M; Mullins JI; Pavlakis GN; Felber BK
PLoS One; 2014; 9(10):e111085. PubMed ID: 25338098
[TBL] [Abstract][Full Text] [Related]
43. Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
Virnik K; Rosati M; Medvedev A; Scanlan A; Walsh G; Dayton F; Broderick KE; Lewis M; Bryson Y; Lifson JD; Ruprecht RM; Felber BK; Berkower I
PLoS One; 2020; 15(3):e0228163. PubMed ID: 32130229
[TBL] [Abstract][Full Text] [Related]
44. IL-12/GM-CSF coadministration in an SIV DNA prime/protein boost protocol enhances Gag-specific T cells but not virus-specific neutralizing antibodies in rhesus macaques.
O'Neill E; Bostik V; Montefiori DC; Kraiselburd E; Villinger F
AIDS Res Hum Retroviruses; 2003 Oct; 19(10):883-90. PubMed ID: 14585220
[TBL] [Abstract][Full Text] [Related]
45. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
[TBL] [Abstract][Full Text] [Related]
46. A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques.
Musich T; Thovarai V; Venzon DJ; Mohanram V; Tuero I; Miller-Novak LK; Helmold Hait S; Rahman MA; Hunegnaw R; Huiting E; Yuan W; O'hUigin C; Hoang T; Sui Y; LaBranche C; Montefiori D; Bear J; Rosati M; Bissa M; Berzofsky JA; Pavlakis GN; Felber BK; Franchini G; Robert-Guroff M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967951
[TBL] [Abstract][Full Text] [Related]
47. Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.
Amara RR; Smith JM; Staprans SI; Montefiori DC; Villinger F; Altman JD; O'Neil SP; Kozyr NL; Xu Y; Wyatt LS; Earl PL; Herndon JG; McNicholl JM; McClure HM; Moss B; Robinson HL
J Virol; 2002 Jun; 76(12):6138-46. PubMed ID: 12021347
[TBL] [Abstract][Full Text] [Related]
48. A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge.
Reynolds MR; Weiler AM; Piaskowski SM; Piatak M; Robertson HT; Allison DB; Bett AJ; Casimiro DR; Shiver JW; Wilson NA; Lifson JD; Koff WC; Watkins DI
Vaccine; 2012 Jun; 30(30):4465-75. PubMed ID: 22569124
[TBL] [Abstract][Full Text] [Related]
49. Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.
Martins MA; Bonaldo MC; Rudersdorf RA; Piaskowski SM; Rakasz EG; Weisgrau KL; Furlott JR; Eernisse CM; Veloso de Santana MG; Hidalgo B; Friedrich TC; Chiuchiolo MJ; Parks CL; Wilson NA; Allison DB; Galler R; Watkins DI
PLoS One; 2013; 8(1):e54434. PubMed ID: 23336000
[TBL] [Abstract][Full Text] [Related]
50. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.
Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP
J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977
[TBL] [Abstract][Full Text] [Related]
51. Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.
Schulte R; Suh YS; Sauermann U; Ochieng W; Sopper S; Kim KS; Ahn SS; Park KS; Stolte-Leeb N; Hunsmann G; Sung YC; Stahl-Hennig C
Virology; 2009 Jan; 383(2):300-9. PubMed ID: 19027133
[TBL] [Abstract][Full Text] [Related]
52. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
Yasutomi Y; Koenig S; Woods RM; Madsen J; Wassef NM; Alving CR; Klein HJ; Nolan TE; Boots LJ; Kessler JA
J Virol; 1995 Apr; 69(4):2279-84. PubMed ID: 7884874
[TBL] [Abstract][Full Text] [Related]
53. Mucosal and systemic SIV-specific cytotoxic CD4
Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C
Sci Rep; 2019 Apr; 9(1):5661. PubMed ID: 30952887
[TBL] [Abstract][Full Text] [Related]
54. Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.
Liu J; Ewald BA; Lynch DM; Nanda A; Sumida SM; Barouch DH
J Virol; 2006 Dec; 80(24):11991-7. PubMed ID: 17005652
[TBL] [Abstract][Full Text] [Related]
55. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
56. Evaluation in rabbits of different anti-SHIV vaccine strategies based on DNA/fowlpox priming and virus-like particle boosting.
Zanotto C; Elli V; Basavecchia V; Brivio A; Paganini M; Pinna D; Vicenzi E; De Giuli Morghen C; Radaelli A
FEMS Immunol Med Microbiol; 2003 Jan; 35(1):59-65. PubMed ID: 12589958
[TBL] [Abstract][Full Text] [Related]
57. Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys.
Subbramanian RA; Kuroda MJ; Charini WA; Barouch DH; Costantino C; Santra S; Schmitz JE; Martin KL; Lifton MA; Gorgone DA; Shiver JW; Letvin NL
J Virol; 2003 Sep; 77(18):10113-8. PubMed ID: 12941922
[TBL] [Abstract][Full Text] [Related]
58. Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection.
Yamamoto T; Johnson MJ; Price DA; Wolinsky DI; Almeida JR; Petrovas C; Nason M; Yeh WW; Shen L; Roederer M; Rao SS; McDermott AB; Lefebvre F; Nabel GJ; Haddad EK; Letvin NL; Douek DC; Koup RA
J Virol; 2012 May; 86(10):5877-84. PubMed ID: 22419810
[TBL] [Abstract][Full Text] [Related]
59. DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.
Vojnov L; Bean AT; Peterson EJ; Chiuchiolo MJ; Sacha JB; Denes FS; Sandor M; Fuller DH; Fuller JT; Parks CL; McDermott AB; Wilson NA; Watkins DI
Vaccine; 2011 Oct; 29(43):7483-90. PubMed ID: 21839132
[TBL] [Abstract][Full Text] [Related]
60. A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques.
Schadeck EB; Sidhu M; Egan MA; Chong SY; Piacente P; Masood A; Garcia-Hand D; Cappello S; Roopchand V; Megati S; Quiroz J; Boyer JD; Felber BK; Pavlakis GN; Weiner DB; Eldridge JH; Israel ZR
Vaccine; 2006 May; 24(21):4677-87. PubMed ID: 16288822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
